Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies

INTRODUCTION: Administration of mesenchymal stem cells (MSCs) has been shown to improve renal function in rodent models of chronic kidney disease (CKD), in part by reducing intrarenal inflammation and suppressing fibrosis. CKD in cats is characterized by tubulointerstitial inflammation and fibrosis,...

Descripción completa

Detalles Bibliográficos
Autores principales: Quimby, Jessica M, Webb, Tracy L, Habenicht, Lauren M, Dow, Steven W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707049/
https://www.ncbi.nlm.nih.gov/pubmed/23632128
http://dx.doi.org/10.1186/scrt198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707049/
https://www.ncbi.nlm.nih.gov/pubmed/23632128
http://dx.doi.org/10.1186/scrt198

Ejemplares similares